Cargando…

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

BACKGROUND: The achievement of glycaemic control remains challenging for patients with type 1 diabetes. We assessed the effectiveness of day-and-night hybrid closed-loop insulin delivery compared with sensor-augmented pump therapy in people with suboptimally controlled type 1 diabetes aged 6 years a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tauschmann, Martin, Thabit, Hood, Bally, Lia, Allen, Janet M, Hartnell, Sara, Wilinska, Malgorzata E, Ruan, Yue, Sibayan, Judy, Kollman, Craig, Cheng, Peiyao, Beck, Roy W, Acerini, Carlo L, Evans, Mark L, Dunger, David B, Elleri, Daniela, Campbell, Fiona, Bergenstal, Richard M, Criego, Amy, Shah, Viral N, Leelarathna, Lalantha, Hovorka, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182127/ https://www.ncbi.nlm.nih.gov/pubmed/30292578 http://dx.doi.org/10.1016/S0140-6736(18)31947-0

Ejemplares similares

Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol
por: Bally, Lia, et al.
Publicado: (2017)

Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial
por: Hovorka, Roman, et al.
Publicado: (2014)

Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study
por: Lawton, Julia, et al.
Publicado: (2019)

Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
por: Elleri, Daniela, et al.
Publicado: (2013)

Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2018)

Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial
por: Tauschmann, Martin, et al.
Publicado: (2016)

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes
por: Tauschmann, Martin, et al.
Publicado: (2015)

Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol
por: Musolino, Gianluca, et al.
Publicado: (2019)

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents
por: Barnard, Katharine D, et al.
Publicado: (2014)

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
por: Boughton, Charlotte K, et al.
Publicado: (2022)

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
por: Boughton, Charlotte, et al.
Publicado: (2020)

Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes
por: Ruan, Yue, et al.
Publicado: (2017)

Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
por: Bally, Lia, et al.
Publicado: (2017)

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study
por: Bally, Lia, et al.
Publicado: (2017)

Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol
por: Leelarathna, Lalantha, et al.
Publicado: (2014)

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014)

Pharmacokinetics of Insulin Aspart in Pump-Treated Subjects With Type 1 Diabetes: Reproducibility and Effect of Age, Weight, and Duration of Diabetes
por: Haidar, Ahmad, et al.
Publicado: (2013)

Safety, efficacy and glucose turnover of reduced prandial boluses during closed‐loop therapy in adolescents with type 1 diabetes: a randomized clinical trial
por: Elleri, D., et al.
Publicado: (2015)

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength
por: Elleri, Daniela, et al.
Publicado: (2014)

COVID-19: Impact of and on Diabetes
por: Schofield, Jonathan, et al.
Publicado: (2020)

Bolusing frequency and amount impacts glucose control during hybrid closed‐loop
por: Bally, L., et al.
Publicado: (2017)

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions
por: Thabit, Hood, et al.
Publicado: (2015)

The impact of using a closed‐loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents
por: Lawton, J., et al.
Publicado: (2019)

Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study
por: Lawton, J., et al.
Publicado: (2018)

Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial
por: Leelarathna, Lalantha, et al.
Publicado: (2013)

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2022)

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery
por: Ruan, Yue, et al.
Publicado: (2015)

Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes
por: Emami, Ali, et al.
Publicado: (2017)

Closed-loop insulin delivery for treatment of type 1 diabetes
por: Elleri, Daniela, et al.
Publicado: (2011)

Unsupervised home use of an overnight closed‐loop system over 3–4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes
por: Thabit, H., et al.
Publicado: (2015)

Closed‐loop insulin delivery in end‐of‐life care: a case report
por: Boughton, C. K., et al.
Publicado: (2019)

Mixed‐meal tolerance test to assess residual beta‐cell secretion: Beyond the area‐under‐curve of plasma C‐peptide concentration
por: Ruan, Yue, et al.
Publicado: (2019)

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Publisher Correction: Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
por: Boughton, Charlotte K., et al.
Publicado: (2021)

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
por: Hovorka, Roman, et al.
Publicado: (2011)

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England
por: Prabhu Navis, Joshi, et al.
Publicado: (2020)

User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics
por: Chen, Natalie S., et al.
Publicado: (2021)

Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol
por: Fuchs, Julia, et al.
Publicado: (2021)

Validity of triple- and dual-tracer techniques to estimate glucose appearance
por: Haidar, A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2ddjeje9naho4gvg3kh1avsn0v